Supporting oncology professionals through education

The content on this site is intended for healthcare professionals only

Videos [595]
News [2024]
Articles [139]
Editorials [6]
Conferences [72]
elearning [20]
Effects of panitumumab against oesophageal-gastro cancer and carcinomas
Dr Tom Waddell – Royal Marsden Hospital, Sutton, UK
Effects of panitumumab against oesophageal-gastro cancer and carcinomas ( Dr Tom Waddell – Royal Marsden Hospital, Sutton, UK )
15 Jun 2012
Regorafenib effective for GISTs that progress due to resistance to approved...
Dr George Demetri - Dana-Farber Cancer Institute, Boston, USA
Regorafenib effective for GISTs that progress due to resistance to approved targeted therapies ( Dr George Demetri - Dana-Farber Cancer Institute, Boston, USA )
13 Jun 2012
President's overview of ASCO 2012
Dr Michael Link - Stanford School of Medicine, California, USA
President's overview of ASCO 2012 ( Dr Michael Link - Stanford School of Medicine, California, USA )
4 Jun 2012
Regorafenib effective for GISTs that progress due to resistance to approved...
Dr George Demetri - Dana Farber Cancer Institute, Boston, USA
Regorafenib effective for GISTs that progress due to resistance to approved targeted therapies ( Dr George Demetri - Dana Farber Cancer Institute, Boston, USA )
4 Jun 2012
Continuing bevacizumab with second-line chemotherapy for colorectal cancer
Dr Dirk Arnold - University Cancer Center Hamburg, Germany
Continuing bevacizumab with second-line chemotherapy for colorectal cancer ( Dr Dirk Arnold - University Cancer Center Hamburg, Germany )
3 Jun 2012
Primary and secondary resistance in colorectal cancer
Dr Silvia Marsoni – The Institute for Cancer Research, Candiolo, Italy
Primary and secondary resistance in colorectal cancer ( Dr Silvia Marsoni – The Institute for Cancer Research, Candiolo, Italy )
21 May 2012
Analysis of thirty years of clinical trial data
Prof Richard Peto - Clinical Trial Service Unit, Oxford University, UK
Analysis of thirty years of clinical trial data ( Prof Richard Peto - Clinical Trial Service Unit, Oxford University, UK )
23 Mar 2012
Infectious diseases as a cause of cancer
Dr Robert Newton - University of York, UK
Infectious diseases as a cause of cancer ( Dr Robert Newton - University of York, UK )
14 Dec 2011
Update on aspirin and cancer prevention
Prof Jack Cuzick - Wolfson Institute of Preventive Medicine, London, UK
Update on aspirin and cancer prevention ( Prof Jack Cuzick - Wolfson Institute of Preventive Medicine, London, UK )
7 Nov 2011
Aspirin for the elderly to reduce cancer risk
Sarah Lyness - Cancer Research UK
Aspirin for the elderly to reduce cancer risk ( Sarah Lyness - Cancer Research UK )
7 Nov 2011
Aspirin and cancer - the patient voice
Dr Keith Spencer - Europacolon
Aspirin and cancer - the patient voice ( Dr Keith Spencer - Europacolon )
7 Nov 2011
Evidence for use of aspirin to prevent cancer
Prof Peter Elwood - Cardiff University, UK
Evidence for use of aspirin to prevent cancer ( Prof Peter Elwood - Cardiff University, UK )
7 Nov 2011

More from ecancer

Register with ecancer to receive our newsletter

Register here

Explore patient resources at ecancerpatient

Visit site

Find out more about ecancer and the work we do

About ecancer

Support ecancer's work by making a donation